CLINICAL_TRIALS
research
· 2026-03-23
Clinical Trial Update: Ebastine Versus Mebeverine in IBS Patients [Phase 3]
Summary
A Phase 3 clinical trial comparing ebastine versus mebeverine in patients with irritable bowel syndrome is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Guy Boeckxstaens | Conditions: IBS - Irritable Bowel Syndrome, IBS | Phase 3 | Status: RECRUITING